Talk:Cancer immunotherapy/Archive 1
 | This is an archive of past discussions about Cancer immunotherapy. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
| Archive 1 |
Some of History not clear - may relate to wider definition of scope
History says "In 1997 rituximab, the first antibody treatment for cancer, was approved by the FDA for treatment of follicular lymphoma. Since this approval, 11 other antibodies have been approved for cancer; alemtuzumab (2001), ofatumumab (2009) and ipilimumab (2011)." but it is not clear if any of these relate to 'cancer immunotherapy' (which is modification of the immune response, NOT the mere use of antibodies) - Rod57 (talk) 21:48, 12 June 2016 (UTC)
... Looks like (from comments above) that some prior editors had a wider definition of Cancer immunotherapy but the excess content has not yet been purged. Any objections to eg that "In 1997 ..." sentence being removed ? - Rod57 (talk) 21:57, 12 June 2016 (UTC)
- Isn't the question not whether the sentence should be removed but whether the 11 antibodies were for cancer immunotherapy? Lfstevens (talk) 07:21, 13 June 2016 (UTC)